Skip to main content
. Author manuscript; available in PMC: 2017 Feb 19.
Published in final edited form as: Int J Tuberc Lung Dis. 2015 Jul;19(7):792–798. doi: 10.5588/ijtld.14.0878

Figure.

Figure

A) Cut-offs for positive and negative IGRA TB-SPOT.TB assays, including grey zone. B) Study flow of HIV-infected women with initial negative IGRA (TB-SPOT.TB) at 32 weeks’ gestation with repeated IGRA testing at 12 months postpartum. SFC = spot-forming cells; IGRA = interferon-gamma release assay; HIV = human immunodeficiency virus.